Mometasone furoate versus betamethasone vale-rate in the treatment of allergic contact dermatitis.
Grandolfo
M
M
Vena
G A
GA
Angelini
G
G
Bianchi
B
B
D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D000368:Aged; D018926:Anti-Allergic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001624:Betamethasone Valerate / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D017449:Dermatitis, Allergic Contact / Q000188:drug therapy*; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D008297:Male; D008875:Middle Aged; D000068656:Mometasone Furoate; D011244:Pregnadienediols / Q000008:administration & dosage / Q000627:therapeutic use*; D016037:Single-Blind Method; D014945:Wound Healing
D018926:Anti-Allergic Agents; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011244:Pregnadienediols; D000068656:Mometasone Furoate; D001624:Betamethasone Valerate